This study aimed to predict therapeutic efficacy among diffuse large B-cell lymphoma (DLBCL) after R-CHOP (-like) therapy using baseline F-fluorodeoxyglucose positron emission tomography (F-FDG PET) radiomics. A total of 239 patients with DLBCL were enrolled in this study, with 82 patients having refractory/relapsed disease. The radiomics signatures were developed using a stacking ensemble approach. The efficacy of the radiomics signatures, the National Comprehensive Cancer Network-International Prognostic Index (NCCN-IPI), conventional PET parameters model, and their combinations in assessing refractory/relapse risk were evaluated using receiver operating characteristic (ROC) curves, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy and decision curve analysis. The stacking model, along with the integrated model that combines stacking with the NCCN-IPI and SDmax (the distance between the two lesions farthest apart, normalized to the patient's body surface area), showed remarkable predictive capabilities with a high area under the curve (AUC), sensitivity, specificity, PPV, NPV, accuracy, and significant net benefit of the AUC (NB-AUC). Although no significant differences were observed between the combined and stacking models in terms of the AUC in either the training cohort (AUC: 0.992 vs. 0.985, = 0.139) or the testing cohort (AUC: 0.768 vs. 0.781, = 0.668), the integrated model exhibited higher values for sensitivity, PPV, NPV, accuracy, and NB-AUC than the stacking model. Baseline PET radiomics could predict therapeutic efficacy in DLBCL after R-CHOP (-like) therapy, with improved predictive performance when incorporating clinical features and SDmax.

Download full-text PDF

Source
http://dx.doi.org/10.1089/cbr.2024.0115DOI Listing

Publication Analysis

Top Keywords

pet radiomics
12
therapeutic efficacy
12
r-chop -like
12
-like therapy
12
npv accuracy
12
f-fdg pet
8
efficacy diffuse
8
diffuse large
8
large b-cell
8
b-cell lymphoma
8

Similar Publications

Article Synopsis
  • Brain tumors are challenging to diagnose and classify in oncology, and radiomics—an emerging field that analyzes quantitative features from medical images—may improve treatment planning despite concerns about study methodologies.
  • A systematic review of literature identified 18 studies using radiomic features and machine learning models to classify gliomas, demonstrating their potential in distinguishing tumor subtypes and grades using various imaging techniques like MRI and PET/CT.
  • The findings suggest that radiomics can achieve high classification accuracy that sometimes surpasses traditional diagnostic methods and the performance of less experienced radiologists, highlighting the need for further validation in clinical practice.
View Article and Find Full Text PDF

Background: Although the integration of positron emission tomography into radiation therapy treatment planning has become part of clinical routine, the best method for tumor delineation is still a matter of debate. In this study, therefore, we analyzed a novel, radiomics-feature-based algorithm in combination with histopathological workup for patients with non-small-cell lung cancer.

Methods: A total of 20 patients with biopsy-proven lung cancer who underwent [F]fluorodeoxyglucose positron emission/computed tomography (FDG-PET/CT) examination before tumor resection were included.

View Article and Find Full Text PDF

: PSMA PET radiomics is a promising tool for primary prostate cancer (PCa) characterisation. However, small single-centre studies and lack of external validation hinder definitive conclusions on the potential of PSMA PET radiomics in the initial workup of PCa. We aimed to validate a radiomics signature in a larger internal cohort and in an external cohort from a separate centre.

View Article and Find Full Text PDF

Multiple myeloma (MM) is the second most prevalent hematologic malignancy, particularly affecting the elderly. The disease often begins with a premalignant phase known as monoclonal gammopathy of undetermined significance (MGUS), solitary plasmacytoma (SP) and smoldering multiple myeloma (SMM). Multiple imaging modalities are employed throughout the disease continuum to assess bone lesions, prevent complications, detect intra- and extramedullary disease, and evaluate the risk of neurological complications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!